Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Found new possible treatments for hair loss.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Skin fat helps with body temperature control and has other active roles in health.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Fat cells are important for tissue repair and stem cell support in various body parts.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Using rodents for research shows that health problems in the womb can cause diseases later in life.